Product
CD3/CD19 neg allogeneic BMT
1 clinical trial
2 indications
Indication
Primary ImmunodeficiencyIndication
Pelvic Inflammatory DiseaseClinical trial
Bilateral Orthotopic Lung Transplant in Tandem With CD3+ and CD19+ Cell Depleted Bone Marrow Transplant From Partially HLA Matched Cadaveric Donors (RTB-003)Status: Completed, Estimated PCD: 2024-03-01